CanSino Biologics Inc (CASBF)
2.83
0.00 (0.00%)
USD |
OTCM |
Jun 20, 16:00
CanSino Biologics Gross Profit Margin (Quarterly): 59.55% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 59.55% |
December 31, 2023 | -518.4% |
September 30, 2023 |
Date | Value |
---|---|
June 30, 2023 | |
March 31, 2023 | 35.17% |
December 31, 2022 | -201.6% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-518.4%
Minimum
Dec 2023
59.55%
Maximum
Mar 2024
-156.3%
Average
-83.19%
Median
Gross Profit Margin (Quarterly) Benchmarks
Sinovac Biotech Ltd | -- |
CASI Pharmaceuticals Inc | 52.98% |
Zai Lab Ltd | 61.42% |
Adagene Inc | -- |
LakeShore Biopharma Co Ltd | 81.92% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -25.77% |
Return on Assets | -16.38% |
Return on Invested Capital | -19.92% |
Profit Margin (Quarterly) | -148.8% |
Operating Margin (Quarterly) | -92.51% |
Return on Net Operating Assets | -28.68% |